Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of drug-resistant infection
3.2.1.2 Advancement in diagnostic technology
3.2.1.3 Rising awareness and training programs in healthcare facilities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High development and implementation cost
3.2.2.2 Competition from alternative solutions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits & reagents
5.3 Instruments & consumables
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Microbiology culture
6.3 Immunoassay
6.4 Polymerase chain reaction (PCR)
6.5 Next generation sequencing (NGS)
6.6 Mass spectrometry
6.7 Rapid & point of care
6.8 Other technologies
Chapter 7 Market Estimates and Forecast, By Pathogen Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Drug-resistant streptococcus pneumoniae (DRSP)
7.3 Drug-resistant campylobacter (DRC)
7.4 Clostridium difficile (CD)
7.5 Drug-resistant neisseria gonorrhoeae (DRNG)
7.6 Other pathogen types
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals & clinics
8.3 Diagnostic laboratories
8.4 Pharmaceutical & biotechnology companies
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Accelerated Diagnostics, USA
10.3 Alifax
10.4 Bio-Rad Laboratories
10.5 BioMerieux
10.6 Beckman Coulter
10.7 Becton, Dickinson and Company
10.8 F. Hoffmann-La Roche
10.9 GeneFluidics
10.10 Molsid
10.11 Thermo Fisher Scientific
10.12 Vela Diagnostics
